About Us
About PhAMA
Industry Overview
FAQ
Contact Us
Our People
Board of Directors
Past Leaders
Secretariat
Members
Join PhAMA
Our Work
Industry Support
Strategic Partnerships
Advocacy
Committees
Capability Building
Resources
International Networks
National Networks
Initiatives
Malaysia Cancer Care Coalition (M3C)
PhAMA Self Care White Paper
Publications
Guiding Principles
Fact Book
Archives
Events
Announcements
DCA letters
14 Sep 2009
Caution Statement on “Possible Interaction between Clopidogrel and Proton Pump Inhibitors” required to be included in the product package insert for Clopidogrel
Source/Author: DCA
Bil (42) dlm. BPFK/PPP/01/03 dated 14th Sept 2009
Source:
www.bpfk.gov.my
Back